Eli Lilly (NYSE: LLY)
Eli Lilly Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Eli Lilly Company Info
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
News & Analysis
9 Best Index Funds for Long-Term Investors
Here are the nine best index funds to add to your portfolio for steady, low-cost growth.
2 Growth Stocks to Buy Hand Over Fist in April
These healthcare companies' target markets substantially overlap.
This 1 Number May Ensure Eli Lilly's Dominance in the Weight Loss Drug Market
Lilly's stock has climbed in the triple digits over the past 12 months.
Eli Lilly's Wegovy Competitor Is Causing Supply Constraints: What It Means for the Stock
Things are going exactly as planned for the biotech giant.
Could This 1 Detail Help Viking Therapeutics Top Eli Lilly and Novo Nordisk in the Weight Loss Drug Market?
Viking shares have soared recently on optimism about its program.
Why Eli Lilly Stock Topped the Market Today
One analyst following the company believes it could grow its revenue meaningfully this year.
Is It Too Late to Buy Eli Lilly Stock?
There's more to the Lilly story than just excellence in one treatment area.
The Largest Companies by Market Cap in 2024
Microsoft, Apple, and Nvidia are the biggest companies measured by market cap.
Valuation
Earnings Transcripts
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
LLY earnings call for the period ending December 31, 2023.
Eli Lilly (LLY) Q3 2023 Earnings Call Transcript
LLY earnings call for the period ending September 30, 2023.
Eli Lilly (LLY) Q2 2023 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2023.
Eli Lilly (LLY) Q1 2023 Earnings Call Transcript
LLY earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.